openPR Logo
Press release

Investigation announced for Investors in Laboratory Corporation of America Holdings (NYSE: LH) over potential Wrongdoing

04-05-2022 04:26 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Laboratory Corporation of America Holdings (NYSE: LH) shares.

An investigation on behalf of investors in Laboratory Corporation of America Holdings (NYSE: LH) shares.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Laboratory Corporation of America Holdings.

Investors who purchased shares of Laboratory Corporation of America Holdings (NYSE: LH) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Laboratory Corporation of America Holdings directors breached their fiduciary duties and caused damage to the company and its shareholders.

Burlington, NC based Laboratory Corporation of America Holdings is an independent clinical laboratory company that offers various tests, including blood chemistry analyses, urinalyses, and blood cell counts. Specifically, Laboratory Corporation of America Holdings's products include a prenatal blood test that purportedly detects developmental problems in the DNA of a fetus with remarkable accuracy.

On January 1, 2022, The New York Times published an article questioning the accuracy of Laboratory Corporation of America Holdings's prenatal blood tests. Specifically, the article indicated, among other things, that the positive results of the prenatal blood tests offered by Labcorp are "incorrect about 85 percent of the time." Additionally, the article revealed that "patients who receive a positive result are supposed to pursue follow-up testing," but that such tests "can cost thousands of dollars, come with a small risk of miscarriage and can't be performed until later in pregnancy."

Shares of Laboratory Corporation of America Holdings (NYSE: LH) declined from $313.04 per share on December 16, 2021, to as low as $264.22 per share on January 24, 2022.

Those who purchased shares of Laboratory Corporation of America Holdings (NYSE: LH) have certain options and should contact the Shareholders Foundation.

Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Laboratory Corporation of America Holdings (NYSE: LH) over potential Wrongdoing here

News-ID: 2594765 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Laboratory

Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia." Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures. Developments in Testing and Preference for Evidence based testing: There is also a rising number
CLINICAL REFERENCE LABORATORY SERVICES Market Latest Development Scenario & Infl …
The CLINICAL REFERENCE LABORATORY SERVICES Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2020-2025). The assessment provides a 360 view and insights, outlining the key outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions for improved profitability. In addition, the study helps venture or private players in
Laboratory Robotics Market Report 2018: Segmentation by Product (Operating Robot …
Global Laboratory Robotics market research report provides company profile for Universal Robots, Anton Paar, AB Controls, Hamilton Robotics, Synchron, Peak Analysis & Automation (PAA), Thermo Fisher Scientific, Tecan Group, Yaskawa Electric, Hudson Robotics and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and
The Institute of Biomedical Laboratory Science-Laboratory Medicine
The Institute of Biomedical Laboratory Science-Laboratory Medicine (IBMLS) is a member organisation for Biomedical Laboratory Scientists in the EU/UK and worldwide. It strives to promote and advance the role of Biomedical Laboratory Science within the healthcare setting to deliver a high quality laboratory service for patients. Biomedical Laboratory Science Online Education (BMLSE) IBMLS provides currently Continuing Professional Development (CPD) education for members through Biomedical Laboratory Science Online Education. This programme includes 30
United States Laboratory Glassware Market Size, Shares, Forecast Report 2017: Ch …
Sales, means the sales volume of Laboratory Glassware Revenue, means the sales value of Laboratory Glassware This report studies sales (consumption) of Laboratory Glassware in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Kimble Chase DURAN Group Bellco Glass Corning Quark Enterprises Wilmad-LabGlass (SP Industries Hamilton Laboratory Glass Kavalierglass Glacier Lab Eagle Laboratory Glass Company BOROSIL Jencons Glass Industries Sibata Scientific Technology Promax Glassco Group Cosmo Laboratory Equipment Hario Pioneer Scientific Instrument SCAM Lab Glass Sichuan Shubo Huaou Industry North Glass Tianbao Glass Instrument Shanghai
Laboratory accreditation imperative for strengthening laboratory systems in Nige …
One of the highly anticipated topics at Medic West Africa is the issue of laboratory accreditation and its importance in strengthening laboratory systems in Nigeria. Air Commodore, Commanding Officer, 445 Nigerian Air Force Laboratory, Dr Edward Abayomi Akinwale will be speaking about this topic during the MEDLAB laboratory conference. The 2nd edition of Medic West Africa will be held from 16 - 18 October 2013 at the Eko Hotel &